Bajaj Healthcare surges on launching Magnesium L-Threonate in Nutraceutical segment
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Bajaj Healthcare is currently trading at Rs. 390.25, up by 16.75 points or 4.48% from its previous closing of Rs. 373.50 on the BSE.
The scrip opened at Rs. 375.95 and has touched a high and low of Rs. 399.00 and Rs. 375.85 respectively. So far 30886 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 511.90 on 09-Jul-2021 and a 52 week low of Rs. 213.48 on 19-Apr-2021.
Last one week high and low of the scrip stood at Rs 399.00 and Rs. 346.90 respectively. The current market cap of the company is Rs. 1075.79 crore.
The promoters holding in the company stood at 67.26%, while Institutions and Non-Institutions held 0.32% and 32.42% respectively.
Bajaj Healthcare has launched Magnesium L-Threonate in Nutraceutical segment. Magnesium L- Threonate is a nutritional supplement used to normalize magnesium level in the body, helps to improve memory, muscle and nerve function and also aids in brain development by reversing the brain aging. It is used to control, prevent and normalize the symptoms associated with Alzheimer’s disease, Attention disorder, Bipolar disorder, Parkinson’s disease etc.
Magnesium L-Threonate is used to prevent the loss of synapses and to improve the cognitive functions of the brain. Magnesium L- Threonate increases the magnesium ion concentration in the brain better than Magnesium Sulphate.
Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.
